Gene therapies are an emerging and exciting space in the biotech world, with the potential to positively impact patient lives all over the industry. Many gene therapy companies are currently working on novel therapeutics for previously untreatable diseases. With the unique potential to restore the function of a gene, gene therapy may allow patients to manage otherwise challenging diseases without the need for ongoing treatment. As pioneering gene therapies move through development, manufacturing, qualification, and ultimately regulatory approval, we’ve gained a better understanding of the development pathway. This allows companies to make informed strategic plans that circumvent hurdles and pitfalls in the development process.

Related Resources
All Resources

post
Oral Drug Product Development of Small Molecules
Read More

white-paper
The New Chemistry, Manufacturing, and Controls (CMC) Regulations in China
Read More

post
Why FDA PreCheck is a game-changer for small & mid-sized pharma — and how these companies should lean in
Read More

white-paper
Solid-Phase Oligonucleotide Synthesis (SPOS) and Liquid-Phase Oligonucleotide Synthesis (LPOS): Complementary or Competitive Processes?
Read More
Let's move from science to success.
Let’s Talk
